How I Treat Newly Diagnosed Hodgkin Lymphoma


Upon viewing this session, you will be able to:
• Describe the different treatment options for Hodgkin lymphoma (HL) patients with early stage disease with attention to individualized risk
• Discuss recently published clinical trial results for HL patients with advanced stage disease
• Review the current treatment options available for older HL patients, including the integration of novel targeted therapeutic agents


  • Andy Andy Evens, DO, Rutgers University, DO, Rutgers University


Member Type Price
List Price $30.00
Active, International, Emeritus, and Honorary Members $20.00
Associate, International Associate, Student, and Resident Members $20.00
back to top